Ameer Kabour

2.1k total citations · 1 hit paper
31 papers, 1.1k citations indexed

About

Ameer Kabour is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ameer Kabour has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ameer Kabour's work include Coronary Interventions and Diagnostics (17 papers), Cardiac Valve Diseases and Treatments (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Ameer Kabour is often cited by papers focused on Coronary Interventions and Diagnostics (17 papers), Cardiac Valve Diseases and Treatments (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (6 papers). Ameer Kabour collaborates with scholars based in United States, Lebanon and Australia. Ameer Kabour's co-authors include Dean J. Kereiakes, Steven O. Marx, Gregg W. Stone, Stephen G. Ellis, Jeffrey J. Popma, Ronald Caputo, Paul S. Teirstein, David G. Rizik, Annapoorna Kini and Marc R. Litt and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Ameer Kabour

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

2015 405 citations Stephen G. Ellis, Dean J. Kereiakes et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Ameer Kabour

Since Specialization

Citations

This map shows the geographic impact of Ameer Kabour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ameer Kabour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ameer Kabour more than expected).

Fields of papers citing papers by Ameer Kabour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ameer Kabour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ameer Kabour. The network helps show where Ameer Kabour may publish in the future.

Co-authorship network of co-authors of Ameer Kabour

This figure shows the co-authorship network connecting the top 25 collaborators of Ameer Kabour. A scholar is included among the top collaborators of Ameer Kabour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ameer Kabour. Ameer Kabour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique 2023 ·Journal of the American College of Cardiology ·Gregg W. Stone, Dean J. Kereiakes, Tommaso Gori, D. Christopher Metzger, Bernardo Stein, Matthew Erickson, Jan Torzewski, Ameer Kabour, (unknown), Jeffrey J. Cavendish, Barry Bertolet, (unknown), Nick E.J. West, Ori Ben‐Yehuda, James W. Choi, Steven O. Marx, John A. Spertus, Stephen G. Ellis	29
2	Impact of systemic lupus erythematosus on in-hospital outcomes of peripheral artery disease—insight from the National Inpatient Sample database 2022 ·Baylor University Medical Center Proceedings ·Jay Shah, (unknown), (unknown), (unknown), Muhammad Junaid Ahsan, (unknown), Syed Sohail Ali, Ameer Kabour, (unknown)	2
3	Medical therapy vs early revascularization in diabetics with chronic total occlusions: A meta-analysis and systematic review 2020 ·World Journal of Cardiology ·(unknown), (unknown), (unknown), Waqas Ullah, (unknown), Khalid Changal, Tanveer Mir, (unknown), Ameer Kabour	2
4	Meta-Analysis of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Low Surgical Risk 2019 ·The American Journal of Cardiology ·Sharath C. Vipparthy, Venkatesh Ravi, (unknown), (unknown), (unknown), Ameer Kabour, Syed Sohail Ali, (unknown), (unknown)	18
5	Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption 2019 ·Circulation ·Dean J. Kereiakes, Stephen G. Ellis, D. Christopher Metzger, Ronald Caputo, David G. Rizik, Paul S. Teirstein, Marc R. Litt, Annapoorna Kini, Ameer Kabour, Steven O. Marx, Jeffrey J. Popma, (unknown), Divine Ediebah, Charles A. Simonton, Gregg W. Stone, (unknown)	61
6	Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial 2017 ·Cardiovascular revascularization medicine ·Ron Waksman, (unknown), Ameer Kabour, Louis Cannon, John Wang, George L. Adams, Naresh Solankhi, (unknown), Dean J. Kereiakes, Roy H. Leiboff, (unknown), Rebecca Torguson, (unknown), Roshni Bastian, (unknown), (unknown), Hans‐Peter Stoll, Héctor M. García‐García	4
7	Risk of Ischemic Heart Disease in Patients With Sjögren’s Syndrome 2017 ·The American Journal of the Medical Sciences ·Faraz Khan Luni, Sonia Malik, Abdur Rahman Khan, Haris Riaz, (unknown), (unknown), (unknown), Osama Dasa, Sadik Khuder, Ameer Kabour	11
8	First and second generation DESs reduce diabetes adverse effect on mortality and re-intervention in multivessel coronary disease: 9-Year analysis 2017 ·Cardiovascular revascularization medicine ·(unknown), Kamellia R. Dimitrova, Yumiko Kanei, Robert F. Tranbaugh, (unknown), Ameer Kabour, Thomas A. Schwann, Samir Alam, Kamal F. Badr, Robert Habib	3
9	Egg Consumption and Incidence of Heart Failure: A Meta-Analysis of Prospective Cohort Studies 2017 ·Frontiers in Nutrition ·Owais Khawaja, (unknown), Faraz Khan Luni, Ameer Kabour, Syed Sohail Ali, (unknown), (unknown), John Michael Gaziano, Luc Djoussé	28
10	3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds 2017 ·Journal of the American College of Cardiology ·Dean J. Kereiakes, Stephen G. Ellis, Christopher Metzger, Ronald Caputo, David G. Rizik, Paul S. Teirstein, Marc R. Litt, Annapoorna Kini, Ameer Kabour, Steven O. Marx, Jeffrey J. Popma, Robert McGreevy, Zhen Zhang, Charles A. Simonton, Gregg W. Stone	194
11	Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease breakdown → 2015 ·New England Journal of Medicine ·Stephen G. Ellis, Dean J. Kereiakes, D. Christopher Metzger, Ronald Caputo, David G. Rizik, Paul S. Teirstein, Marc R. Litt, Annapoorna Kini, Ameer Kabour, Steven O. Marx, Jeffrey J. Popma, Robert McGreevy, Zhen Zhang, Charles A. Simonton, Gregg W. Stone	405
12	Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched analysis 2014 ·Journal of Thoracic and Cardiovascular Surgery ·Laila Al‐Shaar, Thomas A. Schwann, Ameer Kabour, Robert Habib	20
13	THREE–YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE v EVEROLIMUS–ELUTING STENTS 2013 ·Journal of the American College of Cardiology ·Gregg W. Stone, Paul Teirstein, Ian T. Meredith, Robert Stoler, (unknown), Vincent J. Pompili, Ameer Kabour, Thomas Stuckey, Nick Curzen, Shigeru Saito, Andrejs Ērglis, Dominic J. Allocco, Keith D. Dawkins	1
14	Mitral valve repair and bioprosthetic replacement without postoperative anticoagulation does not increase the risk of stroke or mortality 2013 ·European Journal of Cardio-Thoracic Surgery ·Thomas A. Schwann, Milo Engoren, Mark R. Bonnell, Cornelius J. Clancy, Samer Khouri, Ameer Kabour, Tahir Jamil, R. Habib	9
15	Time-Varying Survival Benefit of Radial Artery Versus Vein Grafting: A Multiinstitutional Analysis 2013 ·The Annals of Thoracic Surgery ·Thomas A. Schwann, Robert F. Tranbaugh, Kamellia R. Dimitrova, Milo Engoren, Ameer Kabour, Darryl M. Hoffman, Charles M. Geller, Wilson Ko, Robert Habib	19
16	Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent 2010 ·Journal of the American College of Cardiology ·Dean J. Kereiakes, Louis Cannon, Robert L. Feldman, Jeffrey J. Popma, Raymond D. Magorien, Robert Whitbourn, Ira Dauber, (unknown), (unknown), Barry Bertolet, Ameer Kabour, Michael Foster, John Wang, Paul Underwood, Keith D. Dawkins	50
17	Acute and late outcome after use of 2.5-mm intracoronary stents in small (< 2.5 mm) coronary arteries 2000 ·Catheterization and Cardiovascular Interventions ·Paul L. Huang, Thomas N. Levin, Ameer Kabour, Ted Feldman	12
18	Improved technique for use of half-stents remounted on a stent delivery system 1996 ·Catheterization and Cardiovascular Diagnosis ·Ted Feldman, Ameer Kabour, John D. Carroll, Thomas N. Levin	4
19	Angiotensin II (AII)-Induced Myocyte Necrosis: Role of the AII Receptor 1994 ·Journal of Cardiovascular Pharmacology ·Ameer Kabour, Jeffrey R. Henegar, Joseph S. Janicki	31
20	Myocardial Collagen and Its Functional Role 1993 ·Advances in experimental medicine and biology ·Joseph S. Janicki, Beatriz B. Matsubara, Ameer Kabour	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact